Cargando…

A Case of Abdominal Perforation in a COVID+ Patient Treated With Tocilizumab and Corticosteroids

Coronavirus Disease 2019 (COVID-19) was first identified in Wuhan province in China in late 2019. Around 15% of patients that develop severe acute respiratory syndrome from COVID-19 also develop severe COVID-19 pneumonia. Since the pandemic’s start, various treatments including remdesivir, dexametha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chaudhry, Bilal, Alekseyev, Kirill, Didenko, Lidiya, Chaudhry, Maaria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278419/ https://www.ncbi.nlm.nih.gov/pubmed/37342097 http://dx.doi.org/10.1177/11795476231173870

Ejemplares similares

Longest reported case of symptomatic COVID-19 reporting positive for over 230 days in an immunocompromised patient in the United States
por: Chaudhry, Bilal, et al.
Publicado: (2021)

Rhinocerebral Mucormycosis and COVID-19 Pneumonia
por: Alekseyev, Kirill, et al.
Publicado: (2021)

Post COVID-19 MSSA pneumonia
por: Chaudhry, Bilal, et al.
Publicado: (2021)

Intestinal perforation in patient with COVID-19 infection treated with tocilizumab and corticosteroids. Report of a clinical case()
por: Gonzálvez Guardiola, Paula, et al.
Publicado: (2021)

A Case of Delayed Cecal Perforation After Abdominal (Seat Belt) Injury
por: Okeke, Raymond I, et al.
Publicado: (2022)

Candidemia in COVID‐19 treated with corticosteroids and tocilizumab
por: Yamamoto, Koichiro, et al.
Publicado: (2021)

Tocilizumab and COVID-19
por: Chaudhry, Dhruva, et al.
Publicado: (2020)

Tocilizumab/unspecified corticosteroids: Spinal epidural abscess: 2 case report
Publicado: (2020)

Isolated perforated jejunal diverticulitis: a case report
por: Duggan, William P, et al.
Publicado: (2021)

Corticosteroids/tocilizumab: Reactivation of Mycobacterium tuberculosis following off-label therapy: case report
Publicado: (2020)

Methylprednisolone/tocilizumab: Intestinal perforation following off-label use: case report
Publicado: (2020)

Methylprednisolone/tocilizumab: Intestinal perforation following off-label use: case report
Publicado: (2021)

Methylprednisolone/tocilizumab: Gastrointestinal perforation following off label use: case report
Publicado: (2021)

Tocilizumab: Bowel perforation following off-label use: 2 case reports
Publicado: (2021)

Handlebar Hernia with Triple Herniation and Perforation: A Case Report and Literature Review
por: Shukla, Ankit, et al.
Publicado: (2018)

Severe Adult-onset Still Disease with Constrictive Pericarditis and Pleuritis That Was Successfully Treated with Tocilizumab in Addition to Corticosteroids and Cyclosporin A
por: Kawaguchi, Hoshimi, et al.
Publicado: (2017)

A Recovered Case of COVID-19 Myocarditis and ARDS Treated With Corticosteroids, Tocilizumab, and Experimental AT-001
por: Coyle, Justin, et al.
Publicado: (2020)

Gastrointestinal perforation: relation to corticosteroid use and COPD – a case report
por: Nguyen, Michael H.K., et al.
Publicado: (2016)

Dexamethasone/prednisolone/tocilizumab: Gastrointestinal perforation and off-label use: 3 case reports
Publicado: (2022)

Caecal perforation from TB and the Law of Laplace
por: Khan, Amad N., et al.
Publicado: (2015)

Multiple perforations and fistula formation following corticosteroid administration: A case report
por: He, Jing-Ni, et al.
Publicado: (2017)

Hemophagocytic lymphohistiocytosis in a patient with COVID-19 treated with tocilizumab: a case report
por: Tholin, Birgitte, et al.
Publicado: (2020)

COVID-19 Induced Cardiomyopathy Successfully Treated with Tocilizumab
por: Schreiber, Ariyon, et al.
Publicado: (2022)

Hyperinflammation in COVID-19 Obese Patients Treated With Tocilizumab: A Successful Case Series
por: Beltrão, Beatriz Amorim, et al.
Publicado: (2021)

Tocilizumab: Acute terminal ileum and perforated caecal ulceration following off label use: case report
Publicado: (2020)

Case Study: A Patient with Asthma, Covid-19 Pneumonia and Cytokine Release Syndrome Treated with Corticosteroids and Tocilizumab
por: Schleicher, Gunter K, et al.
Publicado: (2020)

Surgical excision of an abdominal wall granular cell tumour with Permacol(® )mesh reconstruction: a case report
por: Chaudhry, Aisha, et al.
Publicado: (2008)

Long‐term outcomes in corticosteroid‐refractory Graves' orbitopathy treated with tocilizumab
por: Moi, Laura, et al.
Publicado: (2021)

Partial Avulsion of Common Bile Duct and Duodenal Perforation in a Blunt Abdominal Trauma
por: Mirza, Bilal, et al.
Publicado: (2010)

Perforated Gallbladder into the Abdominal Wall
por: Puglisi, M., et al.
Publicado: (2022)

Epoprostenol/hydroxychloroquine/tocilizumab: Acute large bowel perforation, off-label use and lack of efficacy: case report
Publicado: (2020)

First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab
por: Zhang, Xuhan, et al.
Publicado: (2020)

A Case Report of Immune Checkpoint Inhibitor-Induced Aortitis Treated with Tocilizumab
por: Bloomer, Chance H., et al.
Publicado: (2022)

A Rare Case of Rectal Squamous Cell Carcinoma Treated with Nigro Protocol
por: Chaudhry, Hunza, et al.
Publicado: (2022)

In Response to: Corticosteroids in Non-severe COVID-19: Finding Window of Opportunity
por: Nasa, Prashant, et al.
Publicado: (2022)

Tocilizumab in COVID-19: Beware the risk of intestinal perforation
por: Vikse, Jens, et al.
Publicado: (2020)

The Use of Corticosteroids or Tocilizumab in COVID-19 Based on Inflammatory Markers
por: Rubio-Rivas, Manuel, et al.
Publicado: (2021)

Tocilizumab-Associated Small Bowel Perforation in a Young Patient With Rheumatoid Arthritis: A Lesson to Remember During COVID-19 Pandemic
por: Saad, Eltaib, et al.
Publicado: (2022)

Jejunal Perforation Following Blunt Abdominal Trauma; a Case Report
por: Akhgar, Atousa, et al.
Publicado: (2017)

Abdominal Tuberculosis Complicated by Intestinal Perforation
por: Sala, Michiel L., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qg5s6pucmomfu4bpde48432aka